About Precision Medicine Group
Precision Medicine Group is a company based in Bethesda (United States) founded in 2012 by Mark Clein. Precision Medicine Group has raised $257.21 million across 4 funding rounds from investors including Blackstone, TPG and J.H. Whitney Capital Partners. The company has 2,151 employees as of December 31, 2024. Precision Medicine Group has completed 13 acquisitions, including Agility Clinical, Algorics and ApoCell. Precision Medicine Group offers products and services including Biomarker Intelligence, Global CRO, and Specialty Labs. Precision Medicine Group operates in a competitive market with competitors including Charles River Laboratories, Cytel, LabCorp, Frontage Laboratories and Veeda Clinical Research, among others.
- Headquarter Bethesda, United States
- Employees 2151 as on 31 Dec, 2024
- Founders Mark Clein
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Precision Medicine Group, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$257.21 M (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
Blackstone
& 5 more
-
Employee Count
2151
as on Dec 31, 2024
-
Investments & Acquisitions
Agility Clinical
& 12 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Precision Medicine Group
Precision Medicine Group offers a comprehensive portfolio of products and services, including Biomarker Intelligence, Global CRO, and Specialty Labs.
Offers data analysis for biomarker-driven drug development processes.
Provides contract research for global clinical trials and studies.
Delivers central lab and biospecimen management for research needs.
People of Precision Medicine Group
Unlock access to complete
Software Development Team
12 people
Human Resources and Administration
7 people
Leadership Team
5 people
Legal and Compliance
3 people
Sales and Marketing
2 people
Finance and Accounting
1 people
Operations Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of Precision Medicine Group
Precision Medicine Group has successfully raised a total of $257.21M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(02 Apr 2013)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Private Equity Round - Precision Medicine Group | Valuation | Blackstone |
|
| Feb, 2019 | Amount | Private Equity Round - Precision Medicine Group | Valuation |
investors |
|
| Dec, 2015 | Amount | Private Equity Round - Precision Medicine Group | Valuation | TPG |
|
Investors in Precision Medicine Group
Precision Medicine Group has secured backing from 6 investors, including venture fund and angel investors. Prominent investors backing the company include Blackstone, TPG and J.H. Whitney Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified investment management is provided across multiple asset classes.
|
Founded Year | Domain | Location | |
|
Fund of funds focused on pre-seed and seed-stage companies
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
Investments & Acquisitions by Precision Medicine Group
Precision Medicine Group has strategically engaged in corporate development activities, having acquired 13 companies. Notable acquisitions include Agility Clinical, Algorics and ApoCell.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Platform for data analytics and risk management for clinical trials
|
2013 | ||||
|
Provider of digital marketing, data solutions, and medical affair solutions for pharmaceutical industry
|
2013 | ||||
|
Provider of consulting, quality, regulatory, and marketing services to biopharma sector
|
2013 |
Financial Statements - Precision Medicine Group
Precision Medicine Group Comparisons
Competitors of Precision Medicine Group
Precision Medicine Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, LabCorp, Frontage Laboratories and Veeda Clinical Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of drug discovery and preclinical development services
|
|
| domain | founded_year | HQ Location |
Data analysis and statistical solutions are provided for life sciences.
|
|
| domain | founded_year | HQ Location |
Provider of laboratory tests for physicians
|
|
| domain | founded_year | HQ Location |
Early drug development services are provided for pharma firms.
|
|
| domain | founded_year | HQ Location |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
|
Latest news on Precision Medicine Group
Frequently Asked Questions about Precision Medicine Group
Precision Medicine Group was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Precision Medicine Group is headquartered in Bethesda, United States. It is registered at Bethesda, Maryland, United States.
Mark Clein is the current CEO of Precision Medicine Group. They have also founded this company.
Precision Medicine Group is a funded company, having raised a total of $257.21M across 4 funding rounds to date. The company's 1st funding round was a Private Equity Round of $75M, raised on Apr 02, 2013.
As of Dec 31, 2024, the latest employee count at Precision Medicine Group is 2,151.
Precision Medicine Group was founded in 2012 and is headquartered in Bethesda, United States. Operations focus on the life sciences sector, where clinical research, biomarker-driven development, and commercialization services are delivered from product launch to maturity. Offerings include clinical development, specialty labs, commercial consulting, market access, and medical communications. Expertise in lab sciences, translational informatics, regulatory affairs, payer insights, and marketing communications is integrated across services.
Precision Medicine Group's top competitors include LabCorp, Charles River Laboratories and Cytel.
Precision Medicine Group offers Biomarker Intelligence, Global CRO, and Specialty Labs.
Precision Medicine Group has made 13 acquisitions, including Agility Clinical, Algorics, and ApoCell.
Precision Medicine Group has 6 investors. Key investors include Blackstone, TPG, J.H. Whitney Capital Partners, Oak Investment Partners, and Ethan D. Leder.